These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26382970)

  • 1. RTB Lectin: a novel receptor-independent delivery system for lysosomal enzyme replacement therapies.
    Acosta W; Ayala J; Dolan MC; Cramer CL
    Sci Rep; 2015 Sep; 5():14144. PubMed ID: 26382970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.
    Condori J; Acosta W; Ayala J; Katta V; Flory A; Martin R; Radin J; Cramer CL; Radin DN
    Mol Genet Metab; 2016 Feb; 117(2):199-209. PubMed ID: 26766614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RTB lectin-mediated delivery of lysosomal α-l-iduronidase mitigates disease manifestations systemically including the central nervous system.
    Ou L; Przybilla MJ; Koniar B; Whitley CB
    Mol Genet Metab; 2018 Feb; 123(2):105-111. PubMed ID: 29198892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry mice.
    Shen JS; Busch A; Day TS; Meng XL; Yu CI; Dabrowska-Schlepp P; Fode B; Niederkrüger H; Forni S; Chen S; Schiffmann R; Frischmuth T; Schaaf A
    J Inherit Metab Dis; 2016 Mar; 39(2):293-303. PubMed ID: 26310963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Macromolecules to CNS and Other Hard-to-Treat Organs Using Lectin-Mediated Delivery.
    Acosta W; Cramer CL
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein receptor binding, cellular uptake, and lysosomal delivery of fusions between the receptor-associated protein (RAP) and alpha-L-iduronidase or acid alpha-glucosidase.
    Prince WS; McCormick LM; Wendt DJ; Fitzpatrick PA; Schwartz KL; Aguilera AI; Koppaka V; Christianson TM; Vellard MC; Pavloff N; Lemontt JF; Qin M; Starr CM; Bu G; Zankel TC
    J Biol Chem; 2004 Aug; 279(33):35037-46. PubMed ID: 15170390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-glycan structures and downstream mannose-phosphorylation of plant recombinant human alpha-L-iduronidase: toward development of enzyme replacement therapy for mucopolysaccharidosis I.
    Pierce OM; McNair GR; He X; Kajiura H; Fujiyama K; Kermode AR
    Plant Mol Biol; 2017 Dec; 95(6):593-606. PubMed ID: 29119347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo delivery of human alpha-L-iduronidase in mice implanted with neo-organs.
    Salvetti A; Moullier P; Cornet V; Brooks D; Hopwood JJ; Danos O; Heard JM
    Hum Gene Ther; 1995 Sep; 6(9):1153-9. PubMed ID: 8527473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells.
    Baldo G; Quoos Mayer F; Burin M; Carrillo-Farga J; Matte U; Giugliani R
    Cells Tissues Organs; 2012; 195(4):323-9. PubMed ID: 21778683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of alpha-(L)-iduronidase produced by retrovirally transduced fibroblasts into neuronal and glial cells in vitro.
    Stewart K; Brown OA; Morelli AE; Fairbairn LJ; Lashford LS; Cooper A; Hatton CE; Dexter TM; Castro MG; Lowenstein PR
    Gene Ther; 1997 Jan; 4(1):63-75. PubMed ID: 9068797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lectin-deficient ricin toxin intoxicates cells bearing the D-mannose receptor.
    Frankel AE; Fu T; Burbage C; Tagge E; Harris B; Vesely J; Willingham MC
    Carbohydr Res; 1997 May; 300(3):251-8. PubMed ID: 9202409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice.
    Chung S; Ma X; Liu Y; Lee D; Tittiger M; Ponder KP
    Mol Genet Metab; 2007 Feb; 90(2):181-92. PubMed ID: 16979922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein.
    Boado RJ; Hui EK; Lu JZ; Zhou QH; Pardridge WM
    Mol Pharm; 2011 Aug; 8(4):1342-50. PubMed ID: 21667973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
    Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
    Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I.
    Kakkis E; Lester T; Yang R; Tanaka C; Anand V; Lemontt J; Peinovich M; Passage M
    Proc Natl Acad Sci U S A; 2004 Jan; 101(3):829-34. PubMed ID: 14715900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-based endocytosis of a lysosomal enzyme.
    Chen CH; Dellamaggiore KR; Ouellette CP; Sedano CD; Lizadjohry M; Chernis GA; Gonzales M; Baltasar FE; Fan AL; Myerowitz R; Neufeld EF
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15908-13. PubMed ID: 18838694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preproricin expressed in Nicotiana tabacum cells in vitro is fully processed and biologically active.
    Tagge EP; Chandler J; Harris B; Czako M; Marton L; Willingham MC; Burbage C; Afrin L; Frankel AE
    Protein Expr Purif; 1996 Aug; 8(1):109-18. PubMed ID: 8812841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme replacement therapy in feline mucopolysaccharidosis I.
    Kakkis ED; Schuchman E; He X; Wan Q; Kania S; Wiemelt S; Hasson CW; O'Malley T; Weil MA; Aguirre GA; Brown DE; Haskins ME
    Mol Genet Metab; 2001 Mar; 72(3):199-208. PubMed ID: 11243725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice.
    Baldo G; Mayer FQ; Martinelli BZ; de Carvalho TG; Meyer FS; de Oliveira PG; Meurer L; Tavares A; Matte U; Giugliani R
    Mol Genet Metab; 2013 May; 109(1):33-40. PubMed ID: 23562162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-lectin site ricin B chain mutants expressed in insect cells have residual galactose binding: evidence for more than two lectin sites on the ricin toxin B chain.
    Fu T; Burbage C; Tagge E; Chandler J; Willingham M; Frankel A
    Bioconjug Chem; 1996; 7(6):651-8. PubMed ID: 8950484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.